{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-009945","form_type":"8-K","ticker":null,"cik":"0001300734","company_name":"SHINECO, INC.","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.866919+00:00","generated_at":"2026-05-21T13:25:59.966358+00:00","sec_items":["2.01","3.02","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Shineco closes acquisition of 75% of FuWang (HK) for ~US$8.9M cash plus stock","bullets":["Shineco Life Science acquired 75% equity in FuWang (HK) from Yi Yang on May 12, 2025.","Consideration: RMB 63.89M (~US$8.9M) cash, 3,400,000 Shineco shares, and 71.42% of Dream Partner Ltd.","Shares issued under Regulation S; seller represented as non-U.S. person.","Financial statements and pro forma financials to be filed by amendment within 71 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-009945","json":"https://secwatch.observer/filing/0001641172-25-009945.json","markdown":"https://secwatch.observer/filing/0001641172-25-009945.md","text":"https://secwatch.observer/filing/0001641172-25-009945.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1300734/000164117225009945/0001641172-25-009945-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1300734/000164117225009945/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T13:25:59.966358+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"13392b8100ae4ca2b978c5359f8ebdb6bda6b625","claim":"SHINECO, INC. completed an acquisition involving Yi Yang for RMB 63.89 million (approximately US$8.9 million) in cash, 3,400,000 shares of common stock, and 71.42% equity interests in Dream Partner Limited (closed 2025-05-12).","evidence_excerpt":"in FuWang (HK) to Shineco Life Science; therefore, FuWang (HK) became a direct subsidiary of Shineco Life Science. In exchange, Shineco Life Science paid to the Seller RMB 63.89 million (approximately US$8.9 million) in cash, and the Company issued 3,400,000 shares of the Company’s common stock, par value $0.001 per share (the “Shares”) and transferred the","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1300734/000164117225009945/0001641172-25-009945-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Yi Yang"},{"label":"Consideration","value":"RMB 63.89 million (approximately US$8.9 million) in cash, 3,400,000 shares of common stock, and 71.42% equity interests in Dream Partner Limited"},{"label":"Closing","value":"2025-05-12"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}